Jean-François Mayoraz is an attorney in the Corporate and Commercial law business group. He is primarily active in all types of M&A transactions. He is also involved in the provision of advice and the conduct of litigation in corporate, contractual and regulatory matters.
|2019||Attorney at law at Wenger Plattner|
|2018||University of Zurich (Dr. iur.)|
|2017||Trainee at Bär & Karrer AG, Zurich|
|2013||Research assistant to Prof. Dr. Matthias Oesch at the chair for public law, European law and international business law at the University of Zurich|
|2013||Temporary placement at the Consulate General of Switzerland in Shanghai, China|
|2012||Internship with the Directorate of International Law at the Federal Department of Foreign Affairs (FDFA)|
|2012||University of Neuchâtel (Master of Law)|
|2011||University of Zurich (Bachelor of Law)|
Lexology GTDT Labour & Employment 2022 – Switzerland
In: Labour & Employment Switzerland 2022, Lexology, Getting The Deal Through
Newsletter 1/21: Modernisation of Swiss Company Law
After a project lasting ten years, the extensive revision to company law is (finally) being implemented. The provisions relating to gender quotas and transparency rules for commodity companies (both with a transition period) already entered into force on 1 January 2021; the main part will enter into force in 2022. Key features of the new law are the introduction of new principles on corporate governance such as those relating to gender quotas and transparency regulations for commodity companies. The revision also includes a variety of simplified procedures and clarifications, in particular more flexibility for changes to share capital, the permissibility of interim dividends and purely virtual general meetings. Read our newsletter to find out what opportunities the revised law will offer, but also what duties will require action.
The Legal 500 Country Comparative Guides | Switzerland: Employee Incentives
This country-specific Q&A provides an overview of employee incentives laws and regulations applicable in Switzerland.
Beurteilung der Wirtschaftlichkeit von Arzneimitteln im Rahmen der dreijährlichen Überprüfung
Urteil Bundesverwaltungsgerichts BVGer C-6093/2018 vom 17. März 2020, LSR 2020, S. 163
The Pharma Legal Handbook Switzerland
Regulatory, Pricing and Reimbursement Overview · Preclinical and Clinical Trial Requirements · Marketing, Manufacturing, Packaging and Labeling Advertising · Traditional Medicines and OTC Products · Product Liability · Patents and Trademarks · Regulatory Reforms | Pharma Board Room, London 2020
Corona-Pandemie: Verträge in der Krise
Was ist bei Verträgen in der aktuellen Krise zu beachten?
Dr. Jean-François Mayoraz
Attorney at Law
Attorneys at Law Tax Advisors Public Notaries
Seestrasse 39 | P.O. Box
T +41 43 222 38 00
F +41 43 222 38 01
Bar admission (2019)
German, English, French, Chinese